SOPHIA THORMAN: Open Payments
NPI 1861087322 · ASHTABULA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,209 in 39 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,209
Food & beverage: $1,129Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $223 |
| GENZYME CORPORATION | 6 | $186 |
| Galderma Laboratories, L.P. | 3 | $184 |
| ABBVIE INC. | 6 | $150 |
| Biofrontera Inc. | 2 | $105 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| Lilly USA, LLC | 2 | $54 |
| Amgen Inc. | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, SKYRIZI, EBGLYSS, OTEZLA, SPEVIGO, RINVOQ.
Industry payments across OH — which companies pay providers there.
